Pacific Biosciences of California, Inc.

$1.18+2.17%(+$0.03)
TickerSpark Score
44/100
Weak
67
Valuation
35
Profitability
25
Growth
64
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PACB research report →

52-Week Range17% of range
Low $0.85
Current $1.18
High $2.73

Companywww.pacb.com

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases.

CEO
Christian O. Henry
IPO
2010
Employees
575
HQ
Menlo Park, CA, US

Price Chart

+15.21% · this period
$2.67$1.79$0.91May 20Nov 18May 20

Valuation

Market Cap
$364.96M
P/E
-2.79
P/S
2.28
P/B
151.88
EV/EBITDA
-6.92
Div Yield
0.00%

Profitability

Gross Margin
37.08%
Op Margin
-101.72%
Net Margin
-80.34%
ROE
-488.45%
ROIC
-22.69%

Growth & Income

Revenue
$160.00M · 3.89%
Net Income
$-546,376,000 · -76.34%
EPS
$-1.82 · -61.06%
Op Income
$-557,561,000
FCF YoY
46.33%

Performance & Tape

52W High
$2.73
52W Low
$0.85
50D MA
$1.43
200D MA
$1.67
Beta
2.40
Avg Volume
6.07M

Get TickerSpark's AI analysis on PACB

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Apr 8, 26Gibson Christopherother57,473
Apr 8, 26Gibson Christopherother77,842
Apr 1, 26Gibson James R IIsell88,185
Mar 3, 26Gibson Christopherother73,087
Mar 3, 26Gibson Christopherother53,913
Mar 3, 26Gibson Christopherother0
Mar 3, 26HENRY CHRISTIAN Osell12,497
Mar 3, 26Van Oene Marksell6,504
Mar 3, 26Farmer Michelesell2,979
Feb 27, 26Farmer Micheleother89,835

Our PACB Coverage

We haven't published any research on PACB yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate PACB Report →

Similar Companies